SEC Form 4 · accession 0000899243-18-009908
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chen Schor
Officer — President and CEO · Director
Period of report
Apr 10, 2018
Accepted (ET)
Apr 11, 2018 · 8:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 10, 2018 | P | 2,000 | $8.4574 | A | 1,888,363 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4048 to $8.4769, inclusive. The reporting person undertakes to provide to resTORbio, Inc., any security holder of resTORbio, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.